Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-4.41 Insider Own51.78% Shs Outstand57.97M Perf Week3.27%
Market Cap628.13M Forward P/E- EPS next Y-3.77 Insider Trans-10.96% Shs Float28.22M Perf Month19.09%
Income-246.63M PEG- EPS next Q-1.32 Inst Own47.96% Short Float41.80% Perf Quarter5.09%
Sales2.59M P/S242.52 EPS this Y-27.57% Inst Trans6.89% Short Ratio15.19 Perf Half Y43.07%
Book/sh-2.54 P/B- EPS next Y24.83% ROA-98.55% Short Interest11.80M Perf Year-18.96%
Cash/sh5.50 P/C1.95 EPS next 5Y- ROE-3489.00% 52W Range6.07 - 17.02 Perf YTD17.52%
Dividend Est.- P/FCF- EPS past 5Y-137.06% ROI-81.30% 52W High-36.95% Beta0.71
Dividend TTM- Quick Ratio7.80 Sales past 5Y0.00% Gross Margin60.60% 52W Low76.92% ATR (14)0.72
Dividend Ex-Date- Current Ratio7.83 EPS Y/Y TTM9.39% Oper. Margin-7987.20% RSI (14)58.19 Volatility5.35% 6.86%
Employees452 Debt/Eq- Sales Y/Y TTM- Profit Margin-9507.67% Recom1.25 Target Price22.29
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-58.98% Payout- Rel Volume0.38 Prev Close10.89
Sales Surprise17.33% EPS Surprise-7.53% Sales Q/Q- EarningsMay 09 BMO Avg Volume776.53K Price10.73
SMA208.78% SMA509.10% SMA2009.44% Trades Volume291,751 Change-1.47%
Date Action Analyst Rating Change Price Target Change
May-03-24Initiated Stifel Buy $24
Jan-05-24Reiterated Needham Buy $23 → $26
Aug-09-23Initiated H.C. Wainwright Buy $28
May-11-23Upgrade Evercore ISI In-line → Outperform
Mar-13-23Initiated Craig Hallum Buy $21
Oct-21-22Initiated Jefferies Buy $16
May-06-22Downgrade Evercore ISI Outperform → In-line
May-12-21Upgrade Goldman Sell → Neutral $40 → $48
Feb-17-21Initiated BMO Capital Markets Outperform $63
Feb-02-21Initiated Guggenheim Buy $60
May-15-24 08:00AM
May-13-24 11:02AM
May-10-24 08:00AM
May-09-24 09:15AM
08:02AM Loading…
May-03-24 08:02AM
Apr-29-24 08:00AM
Apr-22-24 03:30AM
Apr-19-24 03:03PM
Apr-05-24 06:30PM
Apr-03-24 08:00AM
Mar-26-24 08:00AM
Mar-08-24 03:05PM
01:51PM Loading…
Mar-07-24 01:51PM
Feb-29-24 08:00AM
Feb-13-24 08:00AM
Jan-31-24 08:00AM
Dec-14-23 08:00AM
Dec-06-23 08:00AM
Nov-28-23 08:00AM
Nov-09-23 09:34AM
Nov-01-23 05:00PM
Oct-30-23 08:00AM
Oct-25-23 08:01AM
Sep-26-23 08:01AM
08:00AM Loading…
Sep-05-23 08:00AM
Aug-21-23 08:00AM
Aug-10-23 08:01AM
Aug-09-23 10:26AM
Aug-07-23 02:34PM
Jul-14-23 04:40PM
Jul-10-23 08:26AM
Jul-07-23 08:38AM
Jun-12-23 08:01AM
Jun-09-23 04:01PM
Jun-01-23 09:55AM
May-27-23 09:07AM
May-26-23 09:55AM
May-25-23 09:55AM
May-23-23 07:41PM
May-10-23 08:00AM
May-09-23 08:00AM
Apr-12-23 08:00AM
Apr-10-23 06:44AM
Apr-05-23 08:35AM
Apr-04-23 08:00AM
Mar-27-23 09:55AM
Mar-07-23 12:00PM
Feb-28-23 08:00AM
Feb-10-23 08:53AM
Feb-09-23 04:01PM
Jan-28-23 01:58PM
Jan-24-23 09:02AM
Jan-13-23 06:56AM
Jan-08-23 06:00PM
Jan-06-23 05:02AM
Jan-05-23 11:31AM
Jan-04-23 09:17AM
Jan-03-23 04:01PM
Nov-08-22 05:00PM
Nov-03-22 08:30AM
Nov-01-22 08:00AM
Oct-24-22 08:00AM
Oct-23-22 12:01PM
Oct-18-22 08:00AM
Sep-26-22 08:00AM
Sep-07-22 08:15AM
Aug-17-22 09:16AM
Aug-02-22 08:00AM
Jun-01-22 08:15AM
May-25-22 08:00AM
May-24-22 12:15PM
May-17-22 08:01AM
May-11-22 10:54AM
May-10-22 08:00AM
May-04-22 08:01AM
May-03-22 05:40PM
Apr-26-22 08:00AM
Apr-13-22 02:10PM
Apr-01-22 08:01AM
Mar-22-22 08:02AM
Mar-14-22 08:02AM
Mar-01-22 04:04PM
Feb-11-22 08:52PM
Feb-09-22 04:04PM
Nov-23-21 04:00PM
Nov-12-21 04:30PM
Nov-10-21 08:32PM
Nov-08-21 08:00AM
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Henderson MollyCFO and CBOApr 08 '24Sale11.103,43538,12895,263Apr 10 04:30 PM
Curran TerriePresident and Chief ExecutiveMar 22 '24Sale9.1116,851153,513410,784Mar 26 04:05 PM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJan 24 '24Sale8.103,703,70329,999,9943,755,583Jan 25 06:13 AM
Henderson MollyCFO and CBOJan 19 '24Sale7.756,30748,90098,698Jan 22 08:22 PM
Henderson MollyCFO and CBONov 20 '23Sale7.242,12715,403103,061Nov 21 04:40 PM
Parikh AsitDirectorNov 08 '23Buy7.802,50019,50055,000Nov 08 07:56 PM
Parikh AsitDirectorNov 07 '23Buy7.764,00031,04052,500Nov 08 07:56 PM
Parikh AsitDirectorNov 06 '23Buy8.041,0008,04048,500Nov 08 07:56 PM
Henderson MollyCFO and CBONov 01 '23Sale8.8812,492110,871105,188Nov 03 04:55 PM
Henderson MollyCFO and CBOJun 02 '23Sale11.411,96022,36868,506Jun 05 06:32 PM